These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7982310)

  • 21. Effects of hemodialysis on iodine-131 biokinetics in thyroid carcinoma patients with end-stage chronic renal failure.
    Yeyin N; Cavdar I; Uslu L; Abuqbeitah M; Demir M
    Nucl Med Commun; 2016 Mar; 37(3):283-7. PubMed ID: 26619394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Axillary lymph node metastasis in recurrence of papillary thyroid carcinoma: a case report.
    Ers V; Galant C; Malaise J; Rahier J; Daumerie C
    Wien Klin Wochenschr; 2006 Mar; 118(3-4):124-7. PubMed ID: 16703258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Total thyroidectomy without radioiodine ablation for low-risk thyroid cancer].
    Dralle H
    Chirurg; 2016 Aug; 87(8):698. PubMed ID: 27299751
    [No Abstract]   [Full Text] [Related]  

  • 24. Radioiodine therapy for papillary and follicular thyroid carcinoma.
    Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Radioiodine in the treatment of generalized papillary and follicular thyroid carcinoma].
    Mäenpää H
    Duodecim; 2014; 130(6):573-9. PubMed ID: 24724456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiated thyroid carcinoma: Incremental diagnostic value of
    Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R
    Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer.
    Grünwald F; Menzel C; Fimmers R; Zamora PO; Biersack HJ
    J Nucl Med; 1996 Dec; 37(12):1962-4. PubMed ID: 8970514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of postoperative stimulated thyroglobulin level at the time of 131I ablation therapy for differentiated thyroid cancer.
    Hasbek Z; Turgut B; Kilicli F; Altuntas EE; Yucel B
    Asian Pac J Cancer Prev; 2014; 15(6):2523-7. PubMed ID: 24761858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gamma probe-guided resection of a lymph node metastasis with I-123 in papillary thyroid carcinoma.
    Gallowitsch HJ; Fellinger J; Mikosch P; Kresnik E; Lind P
    Clin Nucl Med; 1997 Sep; 22(9):591-2. PubMed ID: 9298290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 131I treatment of thyroid papillary carcinoma in a patient with renal failure.
    Morrish DW; Filipow LJ; McEwan AJ; Schmidt R; Murland KR; von Westarp C; Betcher KB
    Cancer; 1990 Dec; 66(12):2509-13. PubMed ID: 2249192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma.
    Vaisman A; Orlov S; Yip J; Hu C; Lim T; Dowar M; Freeman JL; Walfish PG
    Head Neck; 2010 Jun; 32(6):689-98. PubMed ID: 20187016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodialysis of chronic kidney failure patients requiring ablative radioiodine therapy.
    Murcutt G; Edwards J; Boakye J; Davenport A
    Kidney Int; 2008 Jun; 73(11):1316-9. PubMed ID: 18354377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Higher administered activities of radioactive iodine are associated with less structural persistent response in older, but not younger, papillary thyroid cancer patients with lateral neck lymph node metastases.
    Sabra MM; Grewal RK; Ghossein RA; Tuttle RM
    Thyroid; 2014 Jul; 24(7):1088-95. PubMed ID: 24559250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized clinical trial comparing 50mCi and 100mCi of iodine-131 for ablation of differentiated thyroid cancers.
    Zaman Mu; Toor R; Kamal S; Maqbool M; Habib S; Niaz K
    J Pak Med Assoc; 2006 Aug; 56(8):353-6. PubMed ID: 16967785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determining patient selection tool and response predictor for outpatient 30 mCi radioiodine ablation dose in non-metastatic differentiated thyroid carcinoma: a Japanese perspective.
    Higuchi T; Achmad A; Binh DD; Bhattarai A; Tsushima Y
    Endocr J; 2018 Mar; 65(3):345-357. PubMed ID: 29343651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyroid carcinoma presenting in childhood or after treatment of childhood malignancies: An institutional experience and review of the literature.
    Gow KW; Lensing S; Hill DA; Krasin MJ; McCarville MB; Rai SN; Zacher M; Spunt SL; Strickland DK; Hudson MM
    J Pediatr Surg; 2003 Nov; 38(11):1574-80. PubMed ID: 14614703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Management of iodine-131 ablation therapy for thyroid carcinoma in a patient on chronic hemodialysis].
    Zenasni N; Elkhayat S; Taleb S; Zamd M; Medkouri G; Benghanem Gharbi M; Ramdani B; Aschawa H; Guensi A
    Nephrol Ther; 2015 Apr; 11(2):114-7. PubMed ID: 25709102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioiodine and radiotherapy in the management of thyroid cancers.
    Simpson WJ
    Otolaryngol Clin North Am; 1990 Jun; 23(3):509-21. PubMed ID: 1694984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyroglobulin-guided (131)I ablation in low-risk differentiated thyroid carcinoma: is the yardstick accurate enough?
    Giovanella L
    Head Neck; 2011 Sep; 33(9):1379-80; author reply 1380-1. PubMed ID: 21739512
    [No Abstract]   [Full Text] [Related]  

  • 40. Results of external beam radiotherapy in patients with well differentiated thyroid carcinoma.
    Lin JD; Tsang NM; Huang MJ; Weng HF
    Jpn J Clin Oncol; 1997 Aug; 27(4):244-7. PubMed ID: 9379512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.